BioSpace News Archive

TESARO Announces U.S. FDA Approval of VARUBI IV fo

Policy

Paratek Completes Submission of NDAs to the FDA for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections

The FDA has previously granted omadacycline both Qualified Infectious Disease Product and Fast Track designation for these indications.

February 5, 2018

·

3 min read

Biotech Beach

Metagenics Joins the UC San Diego Center for Microbiome Innovation as an Industry Sponsor

Metagenics has joined the UC San Diego Center for Microbiome Innovation as an industry sponsor.

February 5, 2018

·

3 min read

Pharm Country

ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Determination

The company is taking definitive steps to satisfy the terms of the Panel’s decision.

February 5, 2018

·

3 min read

Business

Addex Provides Key Financial Indicators and Trading Update

Addex completed 2017 with a cash postion of CHF2.6 million.

February 5, 2018

·

3 min read

University of Copenhagen Installs Latest MILabs VECTor5CT System to Further Accelerate Neuroscience Research.

MILabs announced today that it has successfully completed the installation of its top-of-the-line multimodality PET-SPECT-UHR CT in the laboratory of Prof. Maiken Nedergaard, M.D, D.M.Sci. - Center for Translational Neuroscience, Division of Glial Disease and Therapeutics.

February 5, 2018

·

2 min read

Business

Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Feb. 5, 2018

The stock options have an exercise price of $22.31 per share and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

February 5, 2018

·

1 min read

Business

Parkinson’s Institute and Clinical Center Collaborates with Merck to Evaluate LRRK2 Kinase Inhibition in Preclinical Model of Parkinson’s Disease

The Parkinson’s Institute and Clinical Center has entered into a collaboration with Merck, known as MSD outside the United States and Canada, to study the effects of LRRK2 kinase inhibitors on non-motor symptoms in a preclinical model of gastrointestinal (GI) dysfunction in Parkinson’s disease.

February 5, 2018

·

2 min read

Business

Ligand to Report Fourth Quarter and Full Year 2017 Results on February 21st

Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.

February 5, 2018

·

2 min read

PositiveID’s Chief Science Officer Discusses Company’s Detection of Flu Virus on Its FireflyDX Prototype in Interview With CEOLIVE.TV

Dr. Kimothy Smith discusses importance of point of care/point of need detection during flu season.

February 5, 2018

·

3 min read

Genetown

Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5 in a Topical Application

The authors report that in this single-blind study, wounds were randomized to receive AC5 or control treatment after sequential shave excision of two lesions in the same patient

February 5, 2018

·

6 min read